Yous S - Search Results

1

Conformational analysis of tripeptide Ac-Lys-Pro-Val-NH2, COOH-terminal sequence of alpha-MSH.

Chavatte P, Yous S, Lesieur D, Hénichart JP. Chavatte P, et al. Among authors: yous s. J Pharm Pharmacol. 2001 Jul;53(7):949-53. doi: 10.1211/0022357011776360. J Pharm Pharmacol. 2001. PMID: 11480545

2

Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis.

Chavatte P, Yous S, Marot C, Baurin N, Lesieur D. Chavatte P, et al. Among authors: yous s. J Med Chem. 2001 Sep 27;44(20):3223-30. doi: 10.1021/jm0101343. J Med Chem. 2001. PMID: 11563921

3

Synthesis and pharmacological evaluation of new pyrazolidine-3, 5-diones as AT(1) angiotensin II receptor antagonists.

Le Bourdonnec B, Meulon E, Yous S, Goossens JF, Houssin R, Hénichart JP. Le Bourdonnec B, et al. Among authors: yous s. J Med Chem. 2000 Jul 13;43(14):2685-97. doi: 10.1021/jm9904147. J Med Chem. 2000. PMID: 10893306

4

Comparison of 3D structures and AT(1) binding properties of pyrazolidine-3,5-diones and tetrahydropyridazine-3,6-diones with parent antihypertensive drug irbesartan.

Le Bourdonnec B, Cauvin C, Meulon E, Yous S, Goossens JF, Durant F, Houssin R, Hénichart JP. Le Bourdonnec B, et al. Among authors: yous s. J Med Chem. 2002 Oct 10;45(21):4794-8. doi: 10.1021/jm010457z. J Med Chem. 2002. PMID: 12361407

5

Homology modeling of MT1 and MT2 receptors.

Farce A, Chugunov AO, Logé C, Sabaouni A, Yous S, Dilly S, Renault N, Vergoten G, Efremov RG, Lesieur D, Chavatte P. Farce A, et al. Among authors: yous s. Eur J Med Chem. 2008 Sep;43(9):1926-44. doi: 10.1016/j.ejmech.2007.12.001. Epub 2007 Dec 14. Eur J Med Chem. 2008. PMID: 18255198

6

Synthesis and pharmacological evaluation of analgesic 6-substituted 2(3H)-benzothiazolones.

Yous S, Poupaert JH, Chavatte P, Espiard JG, Caignard DH, Lesieur D. Yous S, et al. Drug Des Discov. 2001;17(4):331-6. Drug Des Discov. 2001. PMID: 11765136

7

Design, synthesis and in vitro evaluation of novel benzo[b]thiophene derivatives as serotonin N-acetyltransferase (AANAT) inhibitors.

Mesangeau C, Yous S, Chavatte P, Ferry G, Audinot V, Boutin JA, Delagrange P, Bennejean C, Renard P, Lesieur D. Mesangeau C, et al. Among authors: yous s. J Enzyme Inhib Med Chem. 2003 Apr;18(2):119-25. doi: 10.1080/1475636031000093552. J Enzyme Inhib Med Chem. 2003. PMID: 12943195 Free article.

8

Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).

Leclerc V, Yous S, Delagrange P, Boutin JA, Renard P, Lesieur D. Leclerc V, et al. Among authors: yous s. J Med Chem. 2002 Apr 25;45(9):1853-9. doi: 10.1021/jm011053+. J Med Chem. 2002. PMID: 11960497

9

Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.

Descamps-François C, Yous S, Chavatte P, Audinot V, Bonnaud A, Boutin JA, Delagrange P, Bennejean C, Renard P, Lesieur D. Descamps-François C, et al. Among authors: yous s. J Med Chem. 2003 Mar 27;46(7):1127-9. doi: 10.1021/jm0255872. J Med Chem. 2003. PMID: 12646022

10

Increased susceptibility of low-density lipoprotein to ex vivo oxidation in mice transgenic for human apolipoprotein B treated with 1 melatonin-related compound is not associated with atherosclerosis progression.

Tailleux A, Gozzo A, Torpier G, Martin-Nizard F, Bonnefont-Rousselot D, Lemdani M, Furman C, Foricher R, Chevé G, Yous S, Micard F, Bordet R, Gardes-Albert M, Lesieur D, Teissier E, Fruchart JC, Fiévet C, Duriez P. Tailleux A, et al. Among authors: yous s. J Cardiovasc Pharmacol. 2005 Sep;46(3):241-9. doi: 10.1097/01.fjc.0000175232.11079.7e. J Cardiovasc Pharmacol. 2005. PMID: 16116326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters